Kyle Ockerman

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker et al. · Nature Immunology · 2022 · 198 citations

Tumor Biology, Immunology, Tumor Immunity +10

Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis

Sabrina H. Han, Rachel Safeek, Kyle Ockerman et al. · Aesthetic Surgery Journal · 2023 · 154 citations · Full text

In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma

Juan Dubrot, Sarah Kate Lane-Reticker, Emily Kessler et al. · Immunity · 2021 · 90 citations · Full text

Immunology, Vivo Screens, Renal Cell Carcinoma +5

Practice Patterns and Perspectives of the Off-Label Use of GLP-1 Agonists for Cosmetic Weight Loss

Sabrina H. Han, Kyle Ockerman, Heather Furnas et al. · Aesthetic Surgery Journal · 2023 · 26 citations · Full text

Bariatric Surgery, Cosmetic Weight Loss, Evidence-based Medicine +25

Regulation of glial size by eicosapentaenoic acid through a novel Golgi apparatus mechanism

Albert Zhang, Ziqiang Guan, Kyle Ockerman et al. · PLoS Biology · 2020 · 13 citations · Full text